Pharmacokinetics of Nicorandil 40 mg Extended-Release Capsules in Healthy Subjects Under Fasting and Fed Conditions.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-506085-31-00

Acronym

AUX-PNI19-PK01

Enrollment

Registered

2023-11-03

Start date

2023-11-27

Completion date

2023-12-20

Last updated

2023-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No medical condition.

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Portugal

None listed

Source: EU CTIS · Data processed: Feb 4, 2026